OCM
AMGN icon

Osbon Capital Management’s Amgen AMGN Stock Holding History

Osbon Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Hold
3,344
– – 0.95% 21
2026
Q1 		$1.18M Buy
3,344
+2,000
+149% +$713K 0.96% 19
2025
Q4 		$440K Buy
+1,344
New +$426K 0.41% 38
2019
Q2 		$285K Buy
+1,547
New +$277K 0.3% 42

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Osbon Capital Management's AMGN Position: Q2 2026 in Review

Osbon Capital Management held its Amgen (AMGN) position steady in Q2 2026 at 3,344 shares worth $1.21M. The position accounts for 0.95% of the portfolio, ranked #21.

Osbon Capital Management first reported a position in AMGN in Q2 2019 and has held it in 4 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Osbon Capital Management held 3,344 shares of Amgen worth $1.21M as of Q2 2026.
  • Osbon Capital Management left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.95% of Osbon Capital Management's portfolio in Q2 2026, its #21 holding.
  • Osbon Capital Management first reported a position in Amgen in Q2 2019 and has held it in 4 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Osbon Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.